Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Taisho Pharmaceutical Holdin (4581 JP)
Watchlist
78
Analysis
Health Care
•
Japan
Taisho Pharmaceutical Holdings Company Ltd. produces and sells pharmaceuticals, foods, and other related products. The Company also provides insurance agency and information processing services and operates hotel businesses.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Vinda International
•
17 Dec 2023 00:00
(Mostly) Asia-Pac Weekly Risk Arb Wrap: Sigma Health, Vinda, Outsourcing, Allkem, Costa, Hollysys
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
827 Views
Share
bullish
•
Benefit One Inc
•
11 Dec 2023 01:09
Merger Arb Mondays (11 Dec) - Benefit One, Outsourcing, Tokyo Rakutenchi, CPMC, Weiqiao Textile
This week, the highest gross spreads are Outsourcing (52.1%), Healius (37.0%), IRC (26.9%), OreCorp (17.4%), Hollysys (16.7%), Tokyo Rakutenchi...
Arun George
Follow
651 Views
Share
bullish
•
Chindata Group
•
10 Dec 2023 07:00
(Mostly) Asia-Pac Weekly Risk Arb Wrap: Perpetual, Weiqiao Textile,Tokyo Rakutenchi,Toyo, Chindata
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
665 Views
Share
bearish
•
Origin Energy
•
04 Dec 2023 00:11
Merger Arb Mondays (4 Dec) - Origin, OreCorp, Healius, CIMC Vehicles, T&K Toka, Eoflow, Hollysys
This week, the highest gross spreads are Eoflow (215.5%), 111 (93.7%), IRC (22.9%), OreCorp (20.8%), Healius (18.7%), Hollysys (15.5%), Origin...
Arun George
Follow
1.3k Views
Share
bullish
•
Taisho Pharmaceutical Holdin
•
03 Dec 2023 22:00
Taisho Pharmaceutical (4581 JP): Japan Catalyst Pushes for a Bump
While justifiable, a bump is unlikely due to the lack of a substantial activist shareholder, irrevocables, no competing bid and the offer’s 55.5%...
Arun George
Follow
679 Views
Share
First
Previous
7
8
9
10
11
12
13
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x